BridgeMD
New treatment option for Lifestyle Intervention
Official title Evaluation of the WARIFA App and Its Impact on Healthy Lifestyle
ClinicalTrials.gov ID: NCT06918444
What this study is testing
- What it's testing
- The goal of this study is to assess the effect of the WARIFA app on the adoption of healthy lifestyle behaviours related to Non-communicable diseases (NCDs), as well as in the management of Type 1 Diabetes (T1D). This is done using user-generated data analysis, artificial intelligence (AI) and risk estimation to provide personalised recommendations on lifestyle-related behaviours through a mobile app.
- Time commitment: about 3 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Common for both population groups:
- Adults over 18 years of age.
- Owners of a smartphone operating with Android and with internet access.
- Group 1: General population:
- Healthy or diagnosed with no more than one NCD (CVD, any type of cancer, T2D or chronic respiratory disease).
You likely can't join if
- Common for both groups:
- Pregnancy.
- Mobile device which is incompatible with the WARIFA app (E.g. Apple devices).
- Unable to understand any of the app languages (Spanish, English, Norwegian or Romanian).
- Any reason which precludes follow-up, based on the researcher's criteria.
- Group 1: General population
See the full eligibility criteria
- Common for both population groups:
- Adults over 18 years of age.
- Owners of a smartphone operating with Android and with internet access.
- Group 1: General population:
- Healthy or diagnosed with no more than one NCD (CVD, any type of cancer, T2D or chronic respiratory disease).
- Group 2: T1D:
- Treatment with multiple subcutaneous insulin injections or an insulin pump.
- Users of a continuous glucose monitor.
- Common for both groups:
- Pregnancy.
- Mobile device which is incompatible with the WARIFA app (E.g. Apple devices).
- Unable to understand any of the app languages (Spanish, English, Norwegian or Romanian).
- Any reason which precludes follow-up, based on the researcher's criteria.
- Group 1: General population
- People with two or more NCDs.
The study team makes the final eligibility decision.
Where it's taking place
- Las Palmas de Gran Canaria, Las Palmas, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Las Palmas de Gran Canaria, Las Palmas, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.